Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma

被引：0
作者：
Anne-Sophie Hamy
Giang-Thanh Lam
Enora Laas
Lauren Darrigues
Thomas Balezeau
Julien Guerin
Alain Livartowski
Benjamin Sadacca
Jean-Yves Pierga
Anne Vincent-Salomon
Florence Coussy
Veronique Becette
Hélène Bonsang-Kitzis
Roman Rouzier
Jean-Guillaume Feron
Gabriel Benchimol
Marick Laé
Fabien Reyal
机构：
[1] Institut Curie,Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab
[2] PSL Research University,Department of Surgery
[3] Institut Curie,Department of Gynecology and Obstetrics
[4] PSL Research University,Department of Medical Informatics and Data
[5] Geneva University Hospitals,Department of Medical Oncology
[6] Institut Curie,Department of Pathology
[7] PSL Research University,Department of Medical Oncology
[8] Institut Curie,Department of Pathology
[9] PSL Research University,Department of Surgery
[10] Institut Curie,Equipe d’Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health
[11] PSL Research University,undefined
[12] Hôpital René Huguenin,undefined
[13] Hôpital René Huguenin,undefined
[14] Hôpital René Huguenin,undefined
[15] University Versailles-Saint-Quentin,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 169卷
关键词：
Breast carcinoma; Lymphovascular invasion; Neoadjuvant chemotherapy; Prognostic scores;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：295 / 304
页数：9
相关论文
共 62 条
[1]  
Lee AHS(2006)Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma Eur J Cancer 42 357-362
[2]  
Pinder SE(2012)The prognostic significance of lymphovascular invasion in invasive breast carcinoma Cancer 118 3670-3680
[3]  
Macmillan RD(2012)Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation Breast J 18 415-419
[4]  
Rakha EA(1996)A computer program to assist in making breast cancer adjuvant therapy decisions Semin Oncol 23 43-50
[5]  
Martin S(2011)Improved web-based calculators for predicting breast carcinoma outcomes Breast Cancer Res Treat 128 827-835
[6]  
Lee AHS(2010)PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer Breast Cancer Res 12 R1-1546
[7]  
Freedman GM(2015)Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Ann Oncol Off J Eur Soc Med Oncol 26 1533-v30
[8]  
Li T(2015)Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 26 v8-564
[9]  
Polli LV(2016)Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy Breast Cancer Res Treat 157 555-4422
[10]  
Ravdin PM(2007)Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol 25 4414-252
1234567